Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19

Aims Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may lead to the development of severe respiratory failure. In hospitalized-patients, prompt interruption of the virus-driven inflammatory process by using combination treatments seems theoretically of outmost importance....

Descripción completa

Detalles Bibliográficos
Autores principales: Dalekos, George N., Stefos, Aggelos, Georgiadou, Sarah, Lygoura, Vasiliki, Michail, Anastasia, Ntaios, George, Samakidou, Anna, Giannoulis, George, Gabeta, Stella, Vlychou, Marianna, Petinaki, Efthymia, Leventogiannis, Konstantinos, Giamarellos-Bourboulis, Evangelos J., Gatselis, Nikolaos K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997723/
https://www.ncbi.nlm.nih.gov/pubmed/33820686
http://dx.doi.org/10.1016/j.ejim.2021.03.026

Ejemplares similares

Ejemplares similares